HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.

Abstract
CD95 (APO-/Fas) ligand (CD95L) is a member of the TNF family predominantly expressed by activated T and NK cells but also by tumors of diverse cellular origin. CD95L trimerizes surface CD95 expressed by target cells that subsequently undergo apoptosis. The role of the CD95/CD95L system in the down-regulation of an immune response (activation-induced cell death) is established. However, it is so far unclear why tumors express CD95L. To investigate whether tumors use the CD95L to down-regulate an anti-tumor immune response, we established a transgenic (tg) mouse model consisting of 1) apoptosis-resistant tumor cells, designated LKC-CD95L, which express functional CD95L and the model tumor Ag K(b); and 2) perforin knockout (PKO) anti-K(b) TCR tg mice. L1210-Fas antisense expressing K(b), crmA, and CD95L (LKC-CD95L) killed CD95(+) unrelated tumor targets and Con A-activated splenocytes from anti-K(b) TCR tg PKO mice by a CD95L-dependent mechanism in vitro. However, we could not detect any cytotoxic activity against anti-tumor (anti-K(b)) T cells in vivo. We also observed reduced growth of LKC-CD95L in nude mice and rapid rejection in anti-K(b) TCR tg PKO mice. Because the tumor cells are resistant to CD95L-, TNF-alpha-, and TNF-related apoptosis-inducing ligand-induced apoptosis and the mice used are perforin-deficient, the involvement of these four cytotoxicity mechanisms in tumor rejection can be excluded. The histological examination of tumors grown in nude mice showed infiltration of LKC-CD95L tumors by neutrophils, whereas L1210-Fas antisense expressing K(b) and crmA (LKC) tumor tissue was neutrophil-free. Chemotaxis experiments revealed that CD95L has no direct neutrophil-attractive activity. Therefore, we conclude that LKC-CD95L cells used an indirect mechanism to attract neutrophils that may cause tumor rejection.
AuthorsC K Behrens, F H Igney, B Arnold, P Möller, P H Krammer
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 166 Issue 5 Pg. 3240-7 (Mar 01 2001) ISSN: 0022-1767 [Print] United States
PMID11207278 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemotactic Factors
  • Fas Ligand Protein
  • Fasl protein, mouse
  • H-2 Antigens
  • H-2Kb protein, mouse
  • Ligands
  • Membrane Glycoproteins
  • Oligonucleotides, Antisense
  • Pore Forming Cytotoxic Proteins
  • Receptors, Antigen, T-Cell
  • Serpins
  • Viral Proteins
  • fas Receptor
  • Perforin
  • interleukin-1beta-converting enzyme inhibitor
Topics
  • Animals
  • COS Cells
  • Cell Division (genetics, immunology)
  • Chemotactic Factors (physiology)
  • Fas Ligand Protein
  • Graft Rejection (genetics, immunology)
  • H-2 Antigens (genetics)
  • Leukemia L1210 (genetics, immunology, pathology, prevention & control)
  • Ligands
  • Membrane Glycoproteins (biosynthesis, deficiency, genetics, physiology)
  • Mice
  • Mice, Inbred DBA
  • Mice, Knockout
  • Mice, Nude
  • Mice, Transgenic
  • Neoplasm Transplantation
  • Oligonucleotides, Antisense (genetics, immunology)
  • Perforin
  • Pore Forming Cytotoxic Proteins
  • Receptors, Antigen, T-Cell (genetics)
  • Serpins (genetics)
  • Solubility
  • Transfection
  • Transgenes (immunology)
  • Viral Proteins
  • fas Receptor (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: